The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Campaigns & Insights
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / October / Rethinking Retinal Regeneration
Research & Innovations Retina Latest News

Rethinking Retinal Regeneration

$2.5 million grant for research into why stem cell-derived retinal cells succeed in some diseased environments but fail in others

10/2/2026 3 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Topic Commentary
Objective:

To investigate how local retinal environments influence the success of stem cell-based therapies for geographic atrophy (GA).

Approach:
  • Funding and Research Focus: Aya Barzelay-Wollman has received $2.5 million from CIRM to study the survival of transplanted retinal cells in various diseased environments.
  • Study of Transition Zone: The research will focus on the retinal transition zone, which contains surviving retinal cells, to identify conditions that support or inhibit transplanted cells.
  • Methodology: Using human donor tissue and stem cell-derived retinal cells, the team will analyze cellular, molecular, and structural features of different retinal environments.
  • Collaboration: The project includes collaboration with Tsu-Chin “T-C.” Tsao for precision robotics expertise.
Key Findings:
  • GA causes progressive vision loss through retinal tissue degeneration.
  • Current treatments do not replace lost tissue, highlighting the need for stem cell-based strategies.
  • Inconsistent graft survival and integration are significant barriers to effective therapies.
Limitations:
  • The study is focused on specific retinal environments and may not generalize to all cases of GA.
  • The effectiveness of modifying unfavorable features of the diseased environment remains to be determined.
Sources:
  • UCLA Health

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: